Summary: Asialoglycoproteins injected into the tail vein of mice accumulated rapidly in the liver, as found in rats and rabbits by other authors, whereas the native glycoprotein remained In the serum for much longer periods of time.
Introduction
Removal of sialic acid from many glycoproteins followed by intravenous injection results in a rapid uptake by the liver and subsequent removal from the serum (1, 2) . This is in contradistinction to the native glycoprotein which remains in the serum for long periods of time. The mechanism whereby asialoglycoproteins are sequestered in the liver has been shown to be dependent, in mammals, on the integrity of terminal Z^-galactosyl residues, which are usually exposed after removal of terminal sialic acid (1) . In birds there appears to be a comparable system involving terminal N-acetyl-Z)-glucosamine (3) .
In addition to a galactose-specific recognition system in mammalian liver, there is some evidence that rats may possess receptors for Z)-mannose and N-acetyl-/)-glucosamine on the Kupffer cell surface in the liver (4) . LFucose will also compete with these two latter monosaccharides for uptake by the liver (4), suggesting that either there are several recognition systems involving different sugars or that a single receptor exists which is unable to distinguish between various glycosyl con^· figurations. Galactose, however, does not affect the uptake of mannose or N-acetyl-glucosamine suggesting a distinct receptor for this monosaccharide, although it has been shown that the D-galactose receptor cannot distinguish between the galactosyl and glucosyl configurations (5) .
Asialoglycoproteins usually possess terminal D-galactosyl residues, which in turn are linked usually to Nacetyl-glucosamine or N-acetyl-galactosamine via a /Jl-4 or 01-3 linkage respectively (6) . These two types of linkages are often indicative of the carbohydrate chain involved. For example, carbohydrate chains of the so-called serum type are usually branched, linked to protein via an N-acetyl-glucosamine/asparagine bond, contain mannose and often have the terminal sequence NANA-Gal(|31-4)-GlcNAc 2 ) (7). In contrast the . . smaller mucin type of chain has an alkali-labile N-acetylgalactosamine/serine or threonine linkage to the protein backbone, does not contain mannose and often has the terminal sequence Ν AN A,Gal(j31-3)-GalN Ac (GalNAc can also be substituted by NANA) (8j). Investigations into the fate of asialo serum glycoproteins, which contain both of these types of carbohydrate chain, may be affected therefore not only by the presence of terminal Z)-galactosyl residues but also by the influence of the sub-terminal sugar and its linkage.
The fate of asialoglycoproteins with the terminal sequence Gal(j31-3)GalNAc. . . is especially interesting as it has been shown that there exists, in most mammals, a naturally occurring antibody directed against this structure (9, 10) . This study was undertaken therefore to examine the clearance of asialoglycoproteins in which the terminal galactosyl residues are present as part of a serum type (alkali-stable) or the mucin (alkali-labile) type of carbohydrate chain and also whether separate mechanisms exist for their removal from the serum.
Experimental
Materials An inbred strain of MRI mice originally purchased from the S ddeutsche Versuchstier-Farm, Tuttlingen were used in all experiments. Human coeruloplasmin, cholinesterase, orosomucoid (<*! acid-glycoprotein), haptoglobin, 0 2 Hi glycoprotein, lactofenin as well as Vibrio choleras neuraminidase (E.G. 3.2.1.18, 500 units/ml) and all general chemicals were obtained from Behringwerke (Marburg/Lahn, F.R.G.). Antifreeze glycoproteins from the Antarctic fish Trematomas borchgrevinki with molecular weights of between 10,500 and 23,500 were isolated as described previously by De Vries et Galactose oxidase (E.G. 1.1.3.9) was obtained from Sigma Ltd., and tritiated acetic anhydride from NEN Chemicals (specific activity 370 GBq/mmol). Sodium borotritiide (specific activity 740 GBq/mmol) was obtained from Amersham/Searle.
Methods

Desialylation of glycoproteins
Glyeoproteins (4.5 mg) were dissolved in phosphate buffered saline (1 ml) and incubated for 24 h at 37 °C with 40 units of neuraminidase in the presence of 10 mmol/1 sodium azide at pH 5.6*Preluninary experiments with all the glycoproteins used showed that these conditions were sufficient to release all the sialic acid. Antifreeze glycoprotein was the only exception as it did not contain any sialic acid. Alternatively, glycoproteins were incubated for l h at 80 °C in the presence of 0.05 mol/1 Η2$Ο 4 , after which the solution was cooled and neutralised with Dowex-1 resin (-OH'form). The resin was removed by centrifugation and the supernatant either stored at -20 °C or lyophilised then stored. Although identical results were obtained with either method, treatment with low concentrations of neuraminidase was preferred.
Monosaccharide analysis of glycoproteins
Monosaccharide analysis was carried out as previously described (12) . Briefly, glycoproteins (1 mg/ml) were incubated with 3 mol/1 HC1 at 100 °C for 4 h, after which the solution was neutralised with silver carbonate. The precipitate of silver chloride was removed by centrifugation. The supernatant and washings were lyophilised, reacetylated (13) and trimethylsilyl derivatives prepared for chromatography (12) . An internal standard of £-erythritol (30 Mg) was included before hydrolysis and the trimethylsilyl-monosaccharides measured by gas chromatography on columns of 3 % OV-17 and 3 % SE-30 on Chromasorb Q (80-100 mesh, Serva). Sialic acid was not routinely determined by gas chromatography but by the method of Aminoff after hydrolytic release in 0.05 mol/1 H 2 SO 4 at 80 °C for l h (14) .
Removal and measurement of the alkaline-labile disaccharide -D-galact osy 1(1 -3) -N-acetyl-D-galactosamine
Glycoproteins (1 mg) were incubated at 37 °C for 24 h with 0.05 mol/1 NaOH containing 1.0 mol/1 NaBH 4 and then neutralised with Dowex 50 resin (-H*-form). The supernatant was removed and the resin washed with water. Supernatant and washings were combined, lyophilised and trimethylsilyl derivatives prepared for gas chromatography in the same way as for monosaccharides. Before alkaline borohydride treatment, glycoproteins were either desialylated by acid hydrolysis or left untreated in order to determine the amount of disaccharide unsubstituted by sialic acid as well as the total amounts. An internal standard of trehalose was included (30 μΐ).
Radiolabelling of glycoproteins
Two methods were used for the radiolabelling of glycoproteins; the galactose oxidase/NaB H 4 technique, in which carbohydrate residues could be labelled arid direct acetylation of the protein chain. For the former method, glycoprotein samples were desialylated as described and then incubated for 20 h at 25 °C with 10 units of galactose pxidase. After oxidation, glycoproteins were reduced by addition of 37-74 MBq of NaB 3 H 4 and incubation at room temperature for 30 min. Reduction was completed by adding excess non-tritiated NaBH 4 (10 mg) with further incubation for 15 min. The glycoproteins were dialysed against phosphate buffered saline (3 X 51), concentrated and volumes adjusted. If not used immediately the aliquots were stored at -20 P C. The second method of radiolabelling was acetylation with tritiated acetic anhydride as has been previously described (15) .
Injection of mice
Varying concentrations of radiolabelled glycoprotein were injected intravenously into mice via the tail vein. After injection the mice were killed by anaesthetising with ether followed by exsanguinatipn and cervical dislocation. This was carried out at periods between 1 and 30 min after injection. Liver, kidney, spleen, blood and urine were routinely removed but in addition from some mice brain, skeletal muscle, heart, lung and bone marrow were also examined. Each organ was weighed immediately after removal, a portion fixed for histological staining and approximately 100 mg taken for radioactive counting.
Measurement of radioactivity in tissues
Organs which were to be counted were cut into small pieces in a glass counting vial and 1 ml of 'NCS Tissue Solubiliser* (Amersham/Seaile, England) added. The samples were then left at 40 °C overnight or until the tissue was completely digested. Any discoloration was removed by briefly heating in the presence of a drop of hydrogen peroxide. Scintillant was added and the samples counted. Radioactivity was expressed as counts/min · g of fresh tissue or as counts/min per whole organ.
Inhibition of glycoprotein uptake
Inhibition experiments were carried out to examine the effect of asialoglycoproteins containing the disaccharide 0-Gal(l-3) GalNAc on the uptake of asialoglycoproteins that do not contain this disaccharide and vice versa. This was done by injection of a non-labelled glycoprotein followed by a second labelled asialoglycoprotein. The second glycoprotein was injected at the time when the first glycoprotein had reached maximum uptake in the liver, usually 10-15 min. The organs were then excised 10-15 min after the injection of the second glycoprotein and counted as described above. Histology Tissue (ca. 100 mg) removed as described above was fixed in 60 g/1 formaldehyde and, after embedding in paraffin wax, sectioned, stained by conventional histochemical staining techniques and then prepared for autoradiography. This was carried out by overlaying the preparation with K 2 Emulsion (Ilford) and exposing the samples for 8-15 days before development.
Results
Analysis of glycoprotein mono and disaccharide content
The amounts of monosaccharides present in the various glycoproteins together with the amount of alkali-labile disaccharide 0-Z?-galactosyl-l -3)-N-acetyl-Z)-galactosamine is summarised in table 1.
It can be seen that cholinesterase and /3 2 IH glycoprotein both contain the above disaccharide and also are the only glycoproteins to possess N-acetyl-galactosamine residues. In addition they contain some mannose and N-acetylglucosamine suggesting the presence of both alkali-labile (AL) and stable chains (AS). Lactoferrin, haptoglobin, orosomucoid and ceruloplasmin contained relatively higher amounts of mannose and N-acetyl-glucosamine, in relation to the total carbohydrate, and no alkali-labile material suggesting that the carbohydrate is present in a serum-type (AS) oligosaccharide chain. Antifreeze glycoprotein was not subjected to analysis because of the small amounts available but it is known from previous data that only galactose and N-acetylgalactosamine are present in a 1:1 ratio and this is linked at every third amino acid in the peptide chain as |3-£)-galactosyl(l -3)-N-acetyl-£>-galactosamine (16, 17, 18) .
The fate of injected asialoglycoproteins
Removal of 100 % of sialic acid prior to injection resulted in a rapid removal of asialoglycoproteins from the serum, which were then taken up by the liver. Maximum label in the liver was found after 10-15 min after which it decreased to less than 50% of maximum approximately 30 min later. The gradual decrease in the amount of radioactivity in the liver could not be detected as an increase in serum levels, although the amount found in the kidney and especially the urine steadily increased. The radioactivity in the urine was difficult to quantify as the volume in the bladder was different with each mouse. Removal of only 25 % of the sialic acid also resulted in uptake by the liver although the peak of maximum uptake occurred about 10 min later ( fig. 1 ). When native glycoproteins were injected no uptake was seen in the liver and serum levels fell only slightly over a 30 min period.
No difference in distribution or uptake were found whether glycoproteins were labelled by galactose oxidase/NaBH 4 or by acetylation. This indicated that the carbohydrate parts of the glycoprotein molecule were not cleaved in vivo and not the explanation for the decrease in radioactivity in the liver after the maximum peak. As a higher specific activity could be obtained with the direct acetylation technique, this was therefore used for most experiments. Antifreeze glycoprotein was always labelled by the galactose oxidase technique, however.
Tissue distribution of injected glycoproteins
With the exception of antifreeze glycoprotein, counting of tissue digests from various organs showed that after injection of asialoglycoproteins most of the radioactivity was localised in the liver. The kidney (and urine) was the only other organ to accumulate any significant activity. The number of counts in the kidney was low in comparison to the liver, although this increased when higher amounts of glycoproteins were injected. Antifreeze glycoprotein and |3 2 HI glycoprotein gave higher recoveries in the kidney than the other glycoproteins, however. This was probably due to their lower molecular weights ( fig. 2 ).
After injection of antifreeze glycoprotein some activity was measurable in the lung. This was not observed with any other glycoprotein. For asialo glycoproteins the liver value is fixed at 1.00. For native glycoglycoproteins serum levels are fixed at 1.00. L = liver; S = serum; K = kidney; Sp = spleen; U = urine; M = muscle; H = heart; Lu = lung; B = bone marrow.
Histological findings
Liver, spleen, bone marrow and heart tissue from mice which had been injected with asialoglycoproteins were examined by autpradiography. Only liver sections showed distinct localised areas of labelling although small amounts of label were present on cells of the reticuloendothelial system in the spleen. Although labelling was detected in the spleen using autoradiography, it was not measurable when pieces of spleen were digested and counted directly in a scintillation counter.
Silver grains in liver preparations were found mainly in the sinus ( fig. 3) . No direct evidence for the binding of asialoglycoproteins to Kupffer cells was obtained, however, areas associated with these cells showed the presence of radiolabelling. Throughout the experimental time course of 30 min, no direct binding to hepatocytes was observed.
Labelling was only seen on the sinusoidal side of the sinus wall. When antifreeze glycoprotein was injected, traces of silver grains were sometimes observed on the surfaces of erythrocytes within the hepatic capillaries.
Effect of chain type on uptake of glycopTOteins Prom table 1 it can be seen that lactoferrin, haptoglobin, orosomucoid and ceruloplasmin contain no alkali labile disaccharide whereas cholinesterase and j3 2 IH glycoprotein probably contain both types of chain. Antifreeze glycoprotein, however, contains only the alkaline labile disaccharide. Injection of the first four glycoproteins all gave kinetics of uptake similar to that shown in figure 1 . Antifreeze glycoprotein was taken up by the liver more slowly. The peak of maximum uptake was consistently observed to be about 5 min later than that of the first four glycoproteins. This did not appear to be related to either the concentration of glycoprotein used or to the amount of galactose in the glycoprotein. Both cholinesterase and j3 2 ΪΠ glycoprotein fell between these two extremes ( fig. 4) .
Inhibition of the uptake of lactpferrin by antifreeze glycoprotein Injection of asialororpsomucoid followed by antifreeze glycoprotein did not affect the uptake of the latter. Similarly prior injection of asialolactofeitin also had no effect on the uptake of antifreeze glycoprotein. By reversing the order of administration it was found that antifreeze glycoprotein could inhibit the uptake of asialolactoferrin by approximately 50 % (tab. 2). 
Discussion
The aim of this work was to investigate the fate of asialoglycoproteins with different types of galactose-containing carbohydrate chains, after intravenous injection into mice. The majority of the labelled material was removed very rapidly from the serum and concentrated in the liver in a manner similar to that demonstrated in rats by Gregoriades et al. (19) . Removal of only a part of the total sialic acid resulted in a slower rate of uptake by the liver, reaching a maximum approximately 5 minutes later after 25 % of the sialic acid had been removed, for example.
The kinetics of uptake of asialoglycoproteins by murine liver were similar to those in the rat, as reported by other authors (19, 20) . After approximately 30 minutes the levels had returned almost to basal level, suggesting that it was being re-released into the serum or metabolised. No significant radioactivity was found in the serum after this time, however, and the increased amounts in kidney and urine would support the latter hypothesis.
Apart from that found in the kidney (and urine) the majority of radioactivity was found in the liver, when measured by scintillation counting of tissue digests. j3 2 III serum glycoprotein and antifreeze glycoprotein appeared in the kidney and urine in higher amounts than any of the other glycoproteins tested, which may be a reflection of the lower molecular weights of these glycoproteins, enabling them to pass directly through the glomerular membrane without prior binding and metabolism in the liver. When higher amounts of glycoproteins were injected, the distribution was identical except that some of the antifreeze glycoprotein localised in the lung. Whether this was due to the presence of a receptor in the lung or whether it is the result of binding of immune complexes to elements of the reticulo-endothelial system (RES) in the lung, is not known.
Examination of autoradiographs of liver sections removed at varying intervals after the injection of asialoglycoproteins suggested that, over a period of 30 minutes, there was no evidence that binding to hepatocytes had occurred. This is in contrast to the findings ofMorell et al. (1) The elegant series of experiments ofMorell, Ashwell and coworkers (1, 2, 22, 23, 24) have clearly shown that a hepatic receptor can be isolated from rats and rabbits which binds asialoglycoproteins selectively and with high affinity in vitro. The results of our experiments, however, have failed to show that asialoglycoproteins, when injected into mice and examined hfetologically, come into contact with the hepatocyte or indeed cross the sinus wall. However, our biochemical measurements support the existence of a receptor for asialoglycoproteins in the liver.
A comparison of glycoproteins with AL galactose containing chains with those containing AS-galactose chains did not in general show any differences in distribution, with the exception of the finding described above in the lung after high levels of antifreeze glycoprotein. Glycoproteins with AS carbohydrate chains were consistently found to be taken up by the liver more rapidly than those with AL carbohydrate chains. This, however, was not dependant on the total amount, of galactose present. Greater numbers of residues per glycoprotein molecule did not necessarily mean a faster rate of uptake.
The possibility of more than one type of receptor specific for galactose has previously been postulated (21) and, although Ashwell &Morell examined the competitive inhibition between asialo-orosomucoid and asialo-cerulo plasmin, the existence of different receptors for glycoproteins with different carbohydrate chains was not considered. Our results, using glycoproteins with AL chains to compete with those possessing AS chains suggested that this could be the case although the results can also be explained by other mechanisms. The four main possibilities are as follows:
1. A single receptor exists and that a terminal galactose residue linked 01 -3 to GalNAc is in a better conformation to bind than one linked via a 01-4 linkage to GlcNAc. 2. The galactose receptor may have an extended site i.e.
one of which galactose is only part and where a second sugar also plays a role. GalNAc may fulfil this function better than GlcNAc. 3. Two receptors may be present both of which bind galactose in the 01-3 linked conformation but only one of which binds galactose residues in the ]31 -4 linked conformation. Thus prior injection of antifreeze glycoprotein (which has a 01-3 linkage) would block both receptors whereas prior injection of asialolactoferrin or asialo-orosomucoid would only block one, not therefore affecting the binding of antifreeze glycoprotein. 4. The in vivo role of anti-TF can be considered. It is known that antifreeze glycoprotein will bind anti-TF (17) although asialolactoferrin or asialo-ceruloplasmin will not (unpublished results). It is possible therefore that glycoproteins containing the disaccharide Gal 031 -3)GalNAc will form immune complexes in vivo which are then bound by cells in the liver (or other cells of the RES). Thus, antifreeze may bind partly to liver cells via terminal galactose residues and partly as immune complexes. Asialo-orosomucoid and asialolactoferrin will only bind via terminal galactose residues however. Prior injection of asialo-lactoferrin would therefore not inhibit the binding of immune complexes but antifreeze may compete for the latter's binding site as well as forming an immune complex.
The true nature of the binding of different glycoproteins is not possible without further investigation but we have endeavoured to show that the assumption that asialoglycoproteins bind to cells in the liver solely by virtue of their exposed galactose residues may not be the only explanation. Consideration of the type of carbohydrate chain and careful histological examination is a necessary requirement for the investigation of the fate of asialoglycoproteins in vivo.
